These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 755381)

  • 21. Treatment of heroin dependence with naltrexone.
    Martin WR
    Curr Psychiatr Ther; 1975; 15():157-61. PubMed ID: 1181122
    [No Abstract]   [Full Text] [Related]  

  • 22. The clinical usefulness of narcotic antagonists: preliminary findings on the use of naltrexone.
    Lewis DC
    Am J Drug Alcohol Abuse; 1975; 2(3-4):403-15. PubMed ID: 1227300
    [No Abstract]   [Full Text] [Related]  

  • 23. Naltrexone and behavior therapy for heroin addiction.
    Rawson RA; Glazer M; Callahan EJ; Liberman RP
    NIDA Res Monogr; 1979 Jun; (25):26-43. PubMed ID: 117373
    [No Abstract]   [Full Text] [Related]  

  • 24. Naltrexone and conventionality.
    Suffet F; Remine DC; Taleporos E; Brotman R
    Am J Drug Alcohol Abuse; 1978; 5(2):221-33. PubMed ID: 747176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naltrexone and psychotherapy.
    Stone-Washton N; Resnick RB; Washton AM
    NIDA Res Monogr; 1982 Apr; 41():505-7. PubMed ID: 6811941
    [No Abstract]   [Full Text] [Related]  

  • 26. Naltrexone in the management of heroin addiction: critique of the rationale.
    Goldstein A
    NIDA Res Monogr; 1976 Sep; (9):158-61. PubMed ID: 187941
    [No Abstract]   [Full Text] [Related]  

  • 27. Does naltrexone affect craving in abstinent opioid-dependent patients?
    Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
    Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of naltrexone to extinguish opioid-conditioned responses.
    O'Brien CP; Childress AR; McLellan AT; Ternes J; Ehrman RN
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):53-6. PubMed ID: 6381473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NIDA's naltrexone research program.
    Julius D
    NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
    [No Abstract]   [Full Text] [Related]  

  • 30. [The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts].
    Yang G; Zhou W; Xu K
    Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):679-82. PubMed ID: 11715458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Operant analysis of human heroin self-administration and the effects of naltrexone.
    Mello NK; Mendelson JH; Kuehnle JC; Sellers MS
    J Pharmacol Exp Ther; 1981 Jan; 216(1):45-54. PubMed ID: 7452507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program.
    Schecter A; Kauders F
    Am J Drug Alcohol Abuse; 1975; 2(3-4):443-9. PubMed ID: 1227302
    [No Abstract]   [Full Text] [Related]  

  • 33. Research and development of naltrexone: a new narcotic antagonist.
    Julius DA
    Am J Psychiatry; 1979 Jun; 136(6):782-6. PubMed ID: 220890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naltrexone study guidelines: good vehicle--wrong destination.
    Brahen LS
    Am J Drug Alcohol Abuse; 1975; 2(3-4):451-3. PubMed ID: 1227303
    [No Abstract]   [Full Text] [Related]  

  • 35. Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study.
    Altman JL; Meyer RE; Mirin SM; McNamee HB
    Int J Addict; 1976; 11(3):485-99. PubMed ID: 184054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naltrexone for heroin addiction: encouraging results from Italy.
    Schifano F; Marra R
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):144-6. PubMed ID: 2338367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Narcotic antagonists: naltrexone progress report: introduction.
    Renault PF
    NIDA Res Monogr; 1976 Sep; (9):1-3. PubMed ID: 794713
    [No Abstract]   [Full Text] [Related]  

  • 38. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of naltrexone.
    Renault PF
    NIDA Res Monogr; 1978; (19):340-5. PubMed ID: 106298
    [No Abstract]   [Full Text] [Related]  

  • 40. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.